Trial intelligence / Profile preview

Acetazolamide for metabolic alkalosis during invasive mechanical ventilation

2010-022901-16Phase 3Completed

Sponsor
Gemma Rialp
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetazolamide in metabolic alkalosis and acute respiratory decompensation, sponsored by Gemma Rialp. Primary endpoints: Duration of mechanical ventilation, Duration of weaning time and 6 more. Started Nov 2010; status: completed.

02

Drugs

acetazolamide
03

Conditions

metabolic alkalosisacute respiratory decompensation

Beyond the preview

Go deeper on 2010-022901-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022901-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call